Marketing Addiction
One marketing expert explained this in my hearing, some years ago. He said that a product like cigarettes, that the customer literally can’t quit using without considerable discomfort-- well, those are the best earners.
Select Page
by C. Scott McMillin | Jan 30, 2023 | Addictive Substances, Public Policy | 0 |
One marketing expert explained this in my hearing, some years ago. He said that a product like cigarettes, that the customer literally can’t quit using without considerable discomfort-- well, those are the best earners.
by C. Scott McMillin | Jan 26, 2023 | Addictive Substances | 0 |
by C. Scott McMillin | Jan 23, 2023 | Addictive Substances | 0 |
by C. Scott McMillin | Jan 16, 2023 | Addictive Substances | 0 |
by C. Scott McMillin | Jan 12, 2023 | Addictive Substances | 0 |
by C. Scott McMillin | Jan 9, 2023 | Addictive Substances | 0 |
by C. Scott McMillin | Dec 1, 2022 | Resources | 0 |
Although to be frank, I don’t know how you’d verify what appeared on the seller’s website. There’s no real regulatory oversight to cross-check the claims, is there?
Read Moreby C. Scott McMillin | Nov 14, 2022 | Addictive Substances | 0 |
Use of higher potency cannabis products does appear to raise the user’s risk of both Cannabis Use Disorders (CUD) and psychosis. The association was less clear for depression and anxiety.
Read Moreby C. Scott McMillin | Oct 20, 2022 | Addictive Substances, In the News | 0 |
I’m sure this is helpful information but I’d be more interested in something new on CUD patients with more severe DSM5 profiles.
Read Moreby C. Scott McMillin | Sep 15, 2022 | In the News | 0 |
A DC lobbyist…filed a suit claiming that John Boehner and an associated law firm had stolen his idea, and the plans for implementing it, without giving him credit (or paying him)
Read Moreby C. Scott McMillin | Aug 25, 2022 | Addictive Substances | 0 |
“choosing to use lower-potency cannabis products could help to make cannabis use safer and offers a sensible strategy for harm reduction.”
Read Moreby C. Scott McMillin | Aug 18, 2022 | Recovery | 0 |
That reminded me of the advice given to newcomers who thought they didn’t need treatment, to “give it your best shot, and if things don’t work out, come back and see us.”
Read Moreby C. Scott McMillin | Aug 8, 2022 | Public Policy | 0 |
One reason to attempt to pass the bill now, as opposed to later, is that the GOP is expected to take over the majority at the beginning of next year.
Read Moreby C. Scott McMillin | Jun 16, 2022 | Addictive Substances | 0 |
I wish cannabis was effective for the treatment of opioid disorders. I mean, we could use the help. But so far, it doesn’t appear to qualify.
Read Moreby C. Scott McMillin | Jun 6, 2022 | Addictive Substances | 0 |
The less good news, if I can call it that, is that none of the three was found to be more effective than our old friend, placebo.
Read Moreby C. Scott McMillin | Jun 2, 2022 | In the News | 0 |
The Gold Rush atmosphere is because everyone is expecting the arrival of bigger, better-funded, publicly-traded cannabis companies, accompanied by their networks of retail stores.
Read Moreby C. Scott McMillin | May 26, 2022 | In the News | 0 |
By the time the authorities get around to questioning it, you’ll have collected more than enough revenue to pay your legal fees.
Read Moreby C. Scott McMillin | May 19, 2022 | Addiction | 0 |
People with well-established patterns of use (including frequent users) have probably learned to self-medicate the discomfort of withdrawal by using more cannabis.
Read More